Cannara Biotech, Inc. · TSX:LOVE
Cannara Biotech — Investor Presentation (March 2026)
23 slides from Cannara Biotech's investor presentation, March 2026
Slide 1: Premium-Quality Cannabis at Scale
TSX: LOVE | OTCQX: LOVFF | FRA: 8CB0 PREMIUM-QUALITY CANNABIS AT SCALE INVESTOR DECK
Slide 2: General Disclosures: Disclaimer
General Disclosures Disclaimer This presentation is qualified in its entirety by reference to, and must be read in conjunction with, the information contained in the Company’s most recent Annual Information Form, as well as in the Company’s most recent consolidated financial statements, together wit
Slide 3: General Disclosures: Forward-Looking Statements
General Disclosures Forward-Looking Statements This presentation may contain “forward-looking information” within the meaning of Canadian securities legislation (“forward-looking statements”). These forward-looking statements are made as of the date of this presentation and the Company does not inte
Slide 4: Cannara: One LOVE
Cannara: One LOVE Canada’s Fastest Growing Top-10 Licensed Producer*. Scalable. Profitable. Proudly Cannara 3 Flagship Brands Scaled Capacity 450+ 50,000 kg Overview Team members Financials HQ: Montreal, Canada Current annualized production Assets Grow: Farnham & Valleyfield with owned high ROI capa
Slide 5: Our Three Pillars
Our Three Pillars A repeatable operating system built for profitable growth Market Discipline SKU discipline + category focus Current 50,000 kg annualized Overview Financials production Assets Strategy Velocity + inventory turns $30M CAPEX plan over 3 years to Performance reach 100,000 kg annualized
Slide 6: Profitability Sets Us Apart
Profitability Sets Us Apart % Change Q1 2025 % Change Q1 2026 Q4 2025 QoQ Comparable Period YoY $42.8M $40.1M 7% $35.9M 19% $30.1M $28.3M 6% $25.0M 20% $13.5M $11.8M 14% $9.8M 38% Overview Financials 45% 42% 7% 39% 15% Assets $8.8M $7.4M 19% $6.0M 47% Strategy Performance 29% 26% 12% 24% 21% Fact Sh
Slide 7: Well Capitalized Balance Sheet
Well Capitalized Balance Sheet Selected Financial Highlights As at November 30, 2025 As at August 31, 2025 % Change Cash $16.5M $14.4 M 14.6% Accounts receivable $15.2M $14.1 M 7.8% Biological assets $5.9M $6.8 M (13.2%) Inventory $46.1M $44.5 M 3.6% Overview Financials Working capital1 $53.5M $48.0
Slide 8: Scaling Sales
Scaling Sales Cannabis Revenue Growth Trajectory as Valleyfield Production Scales Up Cannabis NET Revenue in $ Millions Gross Profit Before Fair Value Adjustment % Gross Margin $30.1 100% $28.3 Overview $27.3 90% $26.6 Financials $24.0 80% Assets $22.1 70% Strategy Performance $18.5 $18.8 $18.3 60%
Slide 9: Two Quebec Based Mega Facilities: Valleyfield
Two Quebec Based Mega Facilities Valleyfield: 1M sq. ft., 24 independent grow rooms, each 25,000 sq. ft. Overview Financials Assets Strategy Performance Fact Sheet Leadership Each activated zone has been designed to replicate indoor growing conditions eliminating variability and maximizing Summary V
Slide 10: Two Quebec Based Mega Facilities: Farnham
Two Quebec Based Mega Facilities Farnham: 605,000 sq. ft., 170, 000 sq. ft. of cannabis operations Overview Financials Assets Strategy Performance Fact Sheet Leadership Summary Farnham Facility • 605,000 sq. ft. facility provides 190,000 sq. ft. of cannabis operations. • R&D Facility (Pheno-hunting,
Slide 11: Disciplined Growth & Expansion
Disciplined Growth & Expansion Cannara’s Estimated Fiscal Year End Production Capacity in kg 120,000 100000 100,000 Annualized Production (kg) 88,000 Overview 80,000 75,000 Financials Assets 65,000 Strategy 60,000 Performance 50,000 50,000 Fact Sheet Leadership 40,000 30,500 33,500 Total owned poten
Slide 12: Capital Deployment & ROI Guardrails
Capital Deployment & ROI Guardrails Phased activation with ROI discipline, aligned to demand What We Fund How We Pace Growth ROI Guardrails Post-processing (gating item) Modest incremental capex per room Unlocks throughput + quality Demand-led activations (activation, not construction) Overview cons
Slide 13: Canadian Recreational Cannabis Market
Canadian Recreational Cannabis Market 2ND Largest Cannabis Market in the world Legal Cannabis Market expected to Monthly Retail Sales of Legal reach Cannabis Stores in Canada from ~$9.81 billion CDN (US$6.58 B) by 20291 October 2018 to December 20252 7 Retail sales in million CDN dollars Overview 6
Slide 14: Why Quebec
Why Quebec Average Electricity Rates By Province In Cents Per Kw Hour Quebec has one of the lowest electricity rates in Canada QC MB BC SK ON AB NS 6.6¢/kWh 7.0¢/kWh 9.4¢/kWh 11.2¢/kWh 12.7¢/kWh 13.7¢/kWh 14.8¢/kWh Overview Financials Assets Quebec has the highest barriers Strategy 578 510 282 151 o
Slide 15: Competitive Advantage
Competitive Advantage Price Community Innovation & Scalable Quality Competitiveness Customer Loyalty Engagement Rare Genetics Premium, craft-style Value-based pricing Consistent repeatable Direct engagement Continuous innovation quality delivered at enabled by Quebec’s experiences with a with consum
Slide 16: National Estimated Retail Sales Growth
National Estimated Retail Sales Growth National Q1 2026 Q4 2025 Licensed Producer $ QoQ Δ % QoQ Δ Sales Rank Total Retail Sales Total Retail Sales 1 Organigram $161.6M $174.8M -$13.2M -8% 2 Tilray $132.3M $138.0M -$5.7M -4% 3 Auxly Cannabis $87.9M $91.1M -$3.2M -3% Overview 4 Cronos $71.3M $70.6M $0
Slide 17: Increasing Our Market Share
Increasing Our Market Share Estimated Retail Market Growth1 Market January 2026 December 2025 Q1 2026 FY 2025 FY 2024 National 4.4% 4.4% 4.1% 3.8% 2.9% QC 14.2% 14.7% 13.5% 12.7% 8.3% ON 3.4% 3.4% 3.1% 2.8% 2.7% Overview AB 2.2% 2.5% 2.5% 2.5% 1.9% Financials BC 2.0% 2.0% 1.8% 1.6% 1.1% Assets Strat
Slide 18: Cannabis CPG Portfolio Leadership
Cannabis CPG Portfolio Leadership Overview Financials Canada’s #1 Infused pre-roll Canada’s #1 Hash rosin brand Canada’s #1 live rosin vape Assets Strategy Performance Fact Sheet Leadership Summary Canada’s #1 CBD flower Canada’s #1 Mass premium Canada’s #1 Premium live resin vape flower brand Mar 2
Slide 19: Cannara Fact Sheet
Cannara Fact Sheet Olymbec Phoenician Market Data (Average Last 30 Days) Capital Structure Investments Capital Ticker LOVE: TSX Basic Shares Outstanding (M) 98.8 (Director) 24% 3% Closing Share Price $1.84 RSUs (M) 0.2 Javaa Options (M) 8.7 Other Private Market Cap $179.1 FD Shares (M) 107.7 Managem
Slide 20: Executive Leadership Team
Executive Leadership Team Zohar is an entrepreneur who has Nicholas Sosiak, CPA, is the Avi has been in the information launched several successful businesses. dynamic and hands-on CFO technology industry for over 20 He has founded, advised and invested of Cannara Biotech, years. He specializes in i
Slide 21: Executive Leadership Team
Executive Leadership Team ZOHAR KRIVOROT DONALD OLDS CHAIRMAN & CEO LEAD DIRECTOR & CHAIRMAN OF THE AUDIT Zohar is a seasoned entrepreneur who has built & GOVERNANCE COMMITTEE and grown multiple successful businesses. He has Donald Olds is an experienced life played pivotal roles as a founder, advis
Slide 22: Strategy Backed by Results
Strategy Backed by Results Premium quality at scale, delivered at disruptive prices, enabled by disciplined execution Overview Premium quality at scale Vertical integration Record Q1 2026 performance Financials cultivation → extraction → packaging and profitability Assets Strategy Disruptive pricing
Slide 23: Thank You
TSX: LOVE | OTCQX: LOVFF | FRA: 8CB0 THANK YOU Overview Financials www.cannara.ca Assets Strategy investors.cannara.ca Performance Fact Sheet www.instagram.com/cannarabiotech Leadership Summary www.facebook.com/cannarabiotech CANNARA HEADQUARTERS FARNHAM FACILITY VALLEYFIELD FACILITY 333 Decarie blv